H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares changing hands.
H. Lundbeck A/S Stock Performance
The company has a 50-day moving average of $22.00 and a 200-day moving average of $22.00. The firm has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Read More
- Five stocks we like better than H. Lundbeck A/S
- What Investors Need to Know About Upcoming IPOs
- How to Invest in Micro-Cap Stocks Like a Pro
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Investors Sell Microsoft Stock on OpenAI News—Time to Buy?
- How to Use the MarketBeat Excel Dividend Calculator
- Take-Two Interactive: A Defensive Play Set to Explode
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.